Konstantinos Makrilakis Selected Research

Atherosclerosis

12/2022	The association of insulin resistance measured through the estimated glucose disposal rate with predictors of micro-and macrovascular complications in patients with type 1 diabetes.
1/2015	The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Konstantinos Makrilakis Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 01/2023 - 07/2010
7	Insulin Resistance 12/2022 - 10/2011
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024 - 07/2008
4	Diabetes Mellitus 04/2024 - 10/2007
4	Inflammation (Inflammations) 01/2020 - 07/2008
3	Obesity 01/2024 - 10/2011
3	Body Weight (Weight, Body) 03/2023 - 02/2012
3	Diabetes Complications 01/2023 - 06/2013
3	Hyperglycemia 01/2023 - 05/2018
3	Hypoglycemia (Reactive Hypoglycemia) 08/2022 - 01/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2015
3	Rheumatoid Arthritis 03/2015 - 01/2015
2	Overweight 01/2024 - 10/2023
2	Prediabetic State (Prediabetes) 03/2023 - 03/2020
2	Atherosclerosis 12/2022 - 01/2015
2	Glycogen Storage Disease (Glycogenosis) 07/2022 - 01/2022
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2022 - 01/2022
2	Neutropenia 07/2022 - 01/2022
2	Glycogen Storage Disease IB 07/2022 - 01/2022
2	Hypertension (High Blood Pressure) 11/2020 - 03/2020
2	Glucose Intolerance 05/2018 - 01/2003
2	Periodontal Diseases (Periodontal Disease) 01/2012 - 02/2011
1	COVID-19 04/2024
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2023
1	Left Ventricular Dysfunction 12/2022
1	Frailty 02/2022
1	Abscess 01/2022
1	Anemia 01/2022
1	Reinfection 01/2022
1	Arteriosclerosis 11/2021
1	Hypertrophy 11/2021
1	Hypotension (Low Blood Pressure) 11/2021
1	Hypercholesterolemia 11/2020
1	Fatty Liver 01/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Neuroinflammatory Diseases 01/2019
1	HIV Infections (HIV Infection) 01/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 06/2013
1	Infections 06/2013
1	Coronary Disease (Coronary Heart Disease) 10/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2011
1	Periodontitis 02/2011

Drug/Important Bio-Agent (IBA)

15	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2003
4	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2015
3	Metformin (Glucophage)FDA LinkGeneric 03/2023 - 05/2018
3	Insulin (Novolin)FDA Link 12/2022 - 01/2019
3	Antihypertensive Agents (Antihypertensives)IBA 11/2020 - 05/2018
2	AntioxidantsIBA 08/2022 - 01/2020
2	empagliflozinIBA 07/2022 - 01/2022
2	Triglycerides (Triacylglycerol)IBA 11/2021 - 02/2012
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2015 - 02/2015
2	C-Reactive ProteinIBA 06/2013 - 01/2012
1	ORALIT (ORS)IBA 01/2024
1	SugarsIBA 01/2024
1	TabletsIBA 10/2023
1	LinagliptinIBA 03/2023
1	SymportersIBA 01/2023
1	SodiumIBA 01/2023
1	Thiobarbituric Acid Reactive SubstancesIBA 08/2022
1	Sodium-Glucose Transport ProteinsIBA 07/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 07/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	LipidsIBA 01/2022
1	lipoprotein cholesterolIBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	CarbohydratesIBA 01/2021
1	glycosylated insulinIBA 10/2020
1	OsteopontinIBA 06/2020
1	CreatinineIBA 01/2020
1	Advanced Glycation End ProductsIBA 01/2020
1	Protein Kinase CIBA 01/2020
1	HexosaminesIBA 01/2020
1	Free RadicalsIBA 01/2020
1	AlbuminsIBA 01/2020
1	Sorbitol (Yal)FDA Link 01/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2018
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2015
1	Atorvastatin (Lipitor)FDA Link 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2013
1	ProcalcitoninIBA 06/2013
1	AldosteroneIBA 06/2013
1	AngiotensinsIBA 06/2013
1	DiureticsIBA 06/2013
1	ReninIBA 06/2013
1	AdiponectinIBA 03/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2012
1	ProinsulinIBA 10/2011
1	Methionine (L-Methionine)FDA Link 07/2010

Therapy/Procedure

5	Therapeutics 01/2020 - 02/2011
3	Glycemic Control 11/2022 - 01/2012
1	Injections 03/2024
1	Activities of Daily Living (ADL) 02/2022
1	High-Protein Low-Carbohydrate Diet (Atkins Diet) 01/2021
1	Root Planing 02/2011
1	Treatment Delay 02/2011
1	Lasers (Laser) 07/2010